Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
CERO CERo Therapeutics	$8.71 +8.8%	$8.77	$6.71 ▼ $895.40	$3.40M	0.46	493,308 shs	65,900 shs
ERNA Ernexa Therapeutics	$1.66 +4.5%	$1.99	$1.50 ▼ $28.80	$12.77M	5.42	309,369 shs	30,232 shs
FLGC Flora Growth	$23.70 -2.5%	$24.37	$15.15 ▼ $82.29	$13.85M	1.97	6,326 shs	5,179 shs
IMCC IM Cannabis	$2.58 -3.2%	$2.84	$1.29 ▼ $7.12	$13.52M	2.2	117,333 shs	41,379 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
CERO CERo Therapeutics	0.00%	+0.63%	-8.36%	-33.63%	-97.26%
ERNA Ernexa Therapeutics	0.00%	-6.76%	-19.95%	-54.06%	-93.86%
FLGC Flora Growth	0.00%	+26.75%	-2.27%	-8.88%	-34.19%
IMCC IM Cannabis	0.00%	-2.92%	-22.22%	+72.27%	-13.77%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
CERO CERo Therapeutics	3.2898 of 5 stars	3.7	3.0	1.9	0.8	0.0
ERNA Ernexa Therapeutics	0.6051 of 5 stars	0.0	3.0	2.4	1.7	0.0
FLGC Flora Growth	3.3279 of 5 stars	3.5	5.0	3.5	0.8	0.6
IMCC IM Cannabis	0.9313 of 5 stars	0.0	5.0	3.3	0.0	0.0

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
CERO CERo Therapeutics	3.33	Buy	$45.00	410.78% Upside
ERNA Ernexa Therapeutics	0.00	N/A	N/A	N/A
FLGC Flora Growth	3.00	Buy	$93.00	289.53% Upside
IMCC IM Cannabis	0.00	N/A	N/A	N/A

Current Analyst Ratings Breakdown

Latest CERO, ERNA, FLGC, and IMCC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/5/2025	FLGC Flora Growth	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Set Price Target	Buy ➝ Buy	$30.00
8/4/2025	CERO CERo Therapeutics	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$30.00
6/23/2025	CERO CERo Therapeutics	D Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Strong-Buy
6/23/2025	CERO CERo Therapeutics	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold ➝ Buy	$30.00
5/30/2025	CERO CERo Therapeutics	D Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
5/30/2025	CERO CERo Therapeutics	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Hold
5/19/2025	CERO CERo Therapeutics	Maxim Group Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$60.00

(Data available from 8/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
CERO CERo Therapeutics	N/A	N/A	N/A	N/A	($41.98) per share	N/A
ERNA Ernexa Therapeutics	$580K	21.83	N/A	N/A	$0.50 per share	3.30
FLGC Flora Growth	$59.51M	0.23	N/A	N/A	$12.21 per share	1.96
IMCC IM Cannabis	$39.44M	0.34	N/A	N/A	$1.03 per share	2.50

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
CERO CERo Therapeutics	-$8.30M	N/A	0.00	∞	N/A	N/A	N/A	-199.71%	N/A
ERNA Ernexa Therapeutics	-$44.54M	-$8.31	N/A	∞	N/A	-7,652.75%	N/A	-682.08%	N/A
FLGC Flora Growth	-$15.91M	-$34.38	N/A	N/A	N/A	-24.86%	-261.57%	-48.06%	N/A
IMCC IM Cannabis	-$7.72M	-$0.54	N/A	N/A	N/A	-4.19%	-59.80%	-5.15%	N/A

Latest CERO, ERNA, FLGC, and IMCC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/13/2025	Q2 2025	ERNA Ernexa Therapeutics	N/A	-$0.61	N/A	-$0.61	N/A	N/A
8/12/2025	Q2 2025	IMCC IM Cannabis	-$0.1367	-$0.0653	+$0.0714	-$0.07	$12.88 million	$9.21 million
8/1/2025	Q2 2025	FLGC Flora Growth	-$0.06	-$0.11	-$0.05	-$0.11	$11.77 million	$14.80 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
CERO CERo Therapeutics	N/A	N/A	N/A	N/A	N/A
ERNA Ernexa Therapeutics	N/A	N/A	N/A	N/A	N/A
FLGC Flora Growth	N/A	N/A	N/A	N/A	N/A
IMCC IM Cannabis	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
CERO CERo Therapeutics	N/A	0.73	0.73
ERNA Ernexa Therapeutics	N/A	1.81	1.81
FLGC Flora Growth	0.50	0.96	0.61
IMCC IM Cannabis	0.32	0.72	0.62

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
CERO CERo Therapeutics	29.64%
ERNA Ernexa Therapeutics	70.55%
FLGC Flora Growth	36.01%
IMCC IM Cannabis	7.68%

Insider Ownership

Company	Insider Ownership
CERO CERo Therapeutics	12.72%
ERNA Ernexa Therapeutics	4.49%
FLGC Flora Growth	12.56%
IMCC IM Cannabis	N/A

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
CERO CERo Therapeutics	8	390,000	337,000	N/A
ERNA Ernexa Therapeutics	10	7.67 million	7.33 million	No Data
FLGC Flora Growth	280	580,000	505,000	Not Optionable
IMCC IM Cannabis	340	5.25 million	N/A	Not Optionable

CERO, ERNA, FLGC, and IMCC Headlines

Recent News About These Companies

IM Cannabis (NASDAQ:IMCC) Rating Lowered to Hold at Wall Street Zen

August 18 at 3:37 AM | americanbankingnews.com

IM Cannabis files to sell 4.98M common shares for holders

August 14, 2025 | msn.com

IM Cannabis Announces Warrant Amendments and Resale Registration Filing

August 14, 2025 | msn.com

IM Cannabis Announces Warrant Amendments and Form F-3 Resale Registration Statement Filing

August 13, 2025 | prnewswire.com

IM Cannabis Reports Second Quarter 2025 Financial Results

August 12, 2025 | prnewswire.com

IM Cannabis to Report Second Quarter 2025 Financial Results on Tuesday, August 12th at 9:00am ET

August 4, 2025 | prnewswire.com

IM Cannabis Closes Private Placement for Gross Proceeds of Approximately US$4.1 Million

July 31, 2025 | prnewswire.com

IM CANNABIS ANNOUNCES FILING OF SHELF REGISTRATION STATEMENT ON FORM F-3

July 11, 2025 | prnewswire.com

IM Cannabis Announces the Signing of a Loan Agreement and Appointment of Oz Adler to Board of Directors

July 9, 2025 | prnewswire.com

IM Cannabis Provides Corporate Updates

July 1, 2025 | prnewswire.com

IM Cannabis (NASDAQ:IMCC) Stock, Earnings Estimates, EPS, And Revenue

June 1, 2025 | benzinga.com

IM Cannabis Stock Price, Quotes and Forecasts | NASDAQ:IMCC | Benzinga

June 1, 2025 | benzinga.com

CSE Bulletin: Delist - IM Cannabis Corp. (IMCC)

May 28, 2025 | newsfilecorp.comN

IM Cannabis Corp.: IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange

May 28, 2025 | finanznachrichten.de

IM Cannabis Announces Plans to Voluntarily Delist from the Canadian Securities Exchange

May 28, 2025 | prnewswire.com

IM Cannabis Provides Corporate Updates

May 27, 2025 | prnewswire.com

IM Cannabis Corp. (IMCC) Q1 2025 Earnings Call Transcript

May 15, 2025 | seekingalpha.com

IM Cannabis Reports First Quarter Financial Results

May 15, 2025 | prnewswire.com

IM Cannabis Announces Filing of Information Circular for Upcoming Annual General and Special Meeting and Provides Additional Information on the Focus Transaction

May 7, 2025 | prnewswire.com

IM Cannabis to Report First Quarter 2025 Financial Results on Thursday, May 15th at 9:00am ET

May 6, 2025 | prnewswire.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All

CERO, ERNA, FLGC, and IMCC Company Descriptions

CERo Therapeutics NASDAQ:CERO

$8.70 +0.71 (+8.81%)

As of 02:53 PM Eastern

CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead program in hematologic malignancies targets an Eat Me signal upregulated on B cell and myeloid tumors. The company is based in South San Francisco, California.

Ernexa Therapeutics NASDAQ:ERNA

$1.66 +0.07 (+4.48%)

As of 02:56 PM Eastern

Eterna Therapeutics Inc., a life science company, provides mRNA cell engineering technologies. Its technologies include mRNA cell reprogramming and gene editing; NoveSlice and UltraSlice gene-editing proteins; and the ToRNAdo mRNA delivery system. The company has a license agreement with Factor Bioscience Limited. Eterna Therapeutics Inc. was founded in 2018 and is based in Cambridge, Massachusetts.

Flora Growth NASDAQ:FLGC

$23.70 -0.60 (-2.47%)

As of 02:55 PM Eastern

Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products worldwide. It operates through three segments: House of Brands, Commercial and Wholesale, and Pharmaceuticals. The company cultivates, processes, and supplies medicinal-grade cannabis flower, and cannabis derived medical and wellness products. It also offers food and beverage, nutraceuticals, cannabis accessories and technology, personal care, and wellness; cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; cannabis consumption accessories, personal storage, and travel accessories for the vape and dry herbs. In addition, the company manufactures and distributes pharmaceutical goods and medical cannabis products to treat a variety of health indications, including drugs related to cancer therapies, attention-deficit/hyperactivity disorder, multiple sclerosis, and anti-depressants. The company sells its products under the JustCBD, Vessel, and Phatebo brands. Flora Growth Corp. was incorporated in 2019 and is based in Fort Lauderdale, Florida.

IM Cannabis NASDAQ:IMCC

$2.58 -0.09 (-3.20%)

As of 02:51 PM Eastern

IM Cannabis Corp. engages in breeding, growing, and supply of medical cannabis products in Israel and Germany. It offers cannabis flowers and strain-specific cannabis extracts under the IMC brand; and dried flower, pre-rolls, minis, and full spectrum extracts offerings under the WAGNERS and BLKMKT brands. The company serves medical patients. IM Cannabis Corp. is headquartered in Tel Aviv, Israel.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time